Forbes July 11, 2024
Mark Travers

The recent surge of medications like Ozempic and Wegovy has sparked debate over the safety of weight loss drugs. From aesthetic and purely superficial concerns like “Ozempic butt” and deeper, more alarming ones like plummeting mental and physical health—wonder weight loss drugs have, inevitably, stoked the already raging fire of weight loss and body image conversations online.

This class of medication, known as “glucagon-like peptide-1 medication,” was initially intended to help treat type 2 diabetes. However, more doctors began prescribing the medication after realizing its potential to aid weight loss.

Such medication helps regulate appetite and curb hunger cues, resulting in weight loss. As the demand for these medications grows, so does concern for the patients it is being prescribed...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Physician, Provider
Expert Insights on How Utilization Management Drives Physician Burnout
Shaping the Future of Cardiology: Key Takeaways From AHA 2024
109 hospitals receiving new Medicare-backed residency slots
STAT+: UnitedHealth pays its own physician groups considerably more than others, driving up consumer costs and its profits
AI Robot Scanner as Good as Rheumatologists at Assessing RA

Share This Article